Study Summary
The purpose of this study is to test the safety of a new investigational acute myeloblastic leukemia (AML) vaccine and see what effects (good and bad) it has on patients with advanced myelodysplasia or acute myelogenous leukemia.
Want to learn more about this trial?
Request More InfoInterventions
autologous tumor cellsBIOLOGICAL
No description available.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | Massachusetts | United States |